John Baron, MD, was interviewed by Charles Bankhead of MedPage Today on March 21, 2012 to give his perspective on three recently published reviews in “The Lancet” and “The Lancet Oncology.” The reviews suggest that “regular aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality.”
Dr. Baron is a professor of medicine in the UNC Division of Gastroenterology and Hepatology and is also a member of UNC Lineberger Comprehensive Cancer Center. In the interview, he talks about the new analysis and how it adds to what we already know about the benefit of aspirin use with regard to cancer.